Does CABOTEGRAVIR Cause Atrioventricular septal defect? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Atrioventricular septal defect have been filed in association with CABOTEGRAVIR (Apretude). This represents 0.1% of all adverse event reports for CABOTEGRAVIR.
10
Reports of Atrioventricular septal defect with CABOTEGRAVIR
0.1%
of all CABOTEGRAVIR reports
6
Deaths
6
Hospitalizations
How Dangerous Is Atrioventricular septal defect From CABOTEGRAVIR?
Of the 10 reports, 6 (60.0%) resulted in death, 6 (60.0%) required hospitalization.
Is Atrioventricular septal defect Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABOTEGRAVIR. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does CABOTEGRAVIR Cause?
Product dose omission issue (1,121)
Off label use (1,049)
Injection site pain (924)
Viral load increased (452)
Pain (399)
Virologic failure (275)
Pathogen resistance (270)
Pyrexia (255)
Product use in unapproved therapeutic environment (234)
Inappropriate schedule of product administration (228)
What Other Drugs Cause Atrioventricular septal defect?
RITONAVIR (29)
LAMIVUDINE (25)
EMTRICITABINE\TENOFOVIR DISOPROXIL (24)
ONDANSETRON (24)
NEVIRAPINE (22)
ABACAVIR (21)
ALPRAZOLAM (21)
ASPIRIN (21)
DIAZEPAM (21)
LAMIVUDINE\ZIDOVUDINE (21)
Which CABOTEGRAVIR Alternatives Have Lower Atrioventricular septal defect Risk?
CABOTEGRAVIR vs CABOTEGRAVIR\RILPIVIRINE
CABOTEGRAVIR vs CABOZANTINIB
CABOTEGRAVIR vs CABOZANTINIB S-MALATE
CABOTEGRAVIR vs CAFFEINE
CABOTEGRAVIR vs CALASPARGASE PEGOL